We are your trusted health partner. Local doorstep deliveries is within the hour .We are Licensed and Regulated by the Pharmacist's Council of Nigeria(PCN).Prices displayed here may differ due to inflation.
Docetaxel 80mg/2mL is a prescription-only, ultra-high-potency taxane chemotherapy medication. It is supplied as a highly concentrated solution containing 80mg of Docetaxel per 2mL of fluid (40mg/mL) inside a single-dose vial.
It is administered exclusively via a slow, controlled intravenous (IV) infusion inside a specialized oncology daycare unit or hospital ward. It is used to treat various advanced, metastatic, or aggressive malignancies, including breast, non-small cell lung, prostate, gastric, and head and neck cancers.
Docetaxel acts as an intensive cellular roadblock, freezing the internal structural machinery that cancer cells need to divide and multiply:
Target-Stabilizes Microtubules: Inside every cell, tiny structural protein tubes called microtubules act like a scaffolding system. Cells must constantly build up and break down this scaffolding to divide. Docetaxel binds tightly to these tubes and locks them in place.
Destroys the Cell Division Cycle: Unlike standard taxanes, Docetaxel targets these tubes with exceptional binding affinity. By permanently locking the cellular framework, it prevents the cancer cell from splitting into two new cells, bringing the replication cycle to an immediate halt.
Triggers Programmed Cell Death: Unable to replicate, the hyperactive cancer cell undergoes programmed cell death (apoptosis), slowing or reversing tumor growth.
Advanced/Metastatic Breast Cancer: Managing advanced breast cancer after standard chemotherapy lines have failed, or as an adjuvant (post-surgery) shield for high-risk node-positive breast cancer.
Non-Small Cell Lung Cancer (NSCLC): Treating advanced or metastatic lung cancer, either alone or combined with platinum-based therapies.
Metastatic Prostate Cancer: First-line management of metastatic castration-resistant prostate cancer (mCRPC), standardly given in combination with an oral corticosteroid (Prednisone).
Advanced Gastric Adenocarcinoma: Treating advanced stomach cancer, standardly combined with cisplatin and 5-fluorouracil.
Head and Neck Cancer: Induction treatment of advanced squamous cell carcinoma of the head and neck.
Docetaxel carries a significant risk of causing severe fluid retention (causing swelling in the legs, ankles, or abdomen, and fluid around the lungs) as well as acute hypersensitivity reactions during the infusion.
🚨 The Strict Premedication Protocol: To minimize fluid retention and lower the risk of severe allergic reactions, every patient must take a protective course of oral corticosteroids before and after their infusion. For non-prostate cancers, this standardly requires Dexamethasone 8mg taken two times a day for 3 consecutive days, starting exactly 1 day before the Docetaxel infusion. ### Severe Bone Marrow Suppression:
It causes a sharp, temporary drop in your white blood cells (neutropenia), which heavily weakens your immune system. Your oncology team will verify a Complete Blood Count (FBC) before every single cycle to ensure your baseline counts are safe before starting the session.
Pregnancy and Breastfeeding: Docetaxel is strictly contraindicated. It causes severe fetal toxicity or death. Highly effective non-hormonal birth control must be used throughout therapy. It must not be used while nursing.
Severe baseline neutropenia (white blood cell count $< 1,500\text{ cells/mm}^3$).
Severe baseline liver impairment, as the liver clears this medication from your blood.
Strictly Professional Clinical IV Use Only: Docetaxel 80mg/2mL is a concentrate that must be diluted in a larger infusion bag of 0.9% Sodium Chloride or 5% Dextrose before use. It must never be given as a rapid injection.
Specialized Non-PVC Tubing: The chemical vehicles in the concentrate can leach dangerous plastic toxins out of standard IV equipment. Medical teams must prepare and run the drug exclusively using glass bottles, polypropylene containers, or non-PVC (polyvinyl chloride) infusion bags and line tubing.
Vigilant Site Tracking: The clinical nurse will closely monitor your injection site throughout the infusion. If the drug accidentally leaks out of the vein into the surrounding arm tissue (extravasation), it can cause severe tissue irritation and localized skin damage.
1.Verify your 3-day oral steroid schedule:Pre-Chemo Compliance.
The oncology nurse will verify that you successfully took your dexamethasone tablets the day before your appointment to ensure your body is fully shielded.
2.Confirm FBC parameters are completely safe:Blood Count Clearance.
Your morning blood test results are checked to ensure your white blood cells and immune defense baseline have fully recovered from any prior cycles.
3.Run the Docetaxel smoothly over 1 hour:Controlled Infusion.
The diluted 80mg solution is infused slowly through non-PVC lines, while the clinical team routinely monitors your heart rate, blood pressure, and breathing.
4.Monitor at home and track your temperature:Home Tracking.
Rest at home following the session. Monitor your temperature daily and immediately contact your care team if you experience any unexpected changes.
As your system interacts with this intensive chemotherapy compound, you will experience typical targeted updates:
Total Hair Loss (Alopecia): Complete and rapid loss of body hair, including scalp hair, eyebrows, and eyelashes. Hair standardly grows back after the entire treatment course ends.
Nail Alterations: Your fingernails and toenails may become brittle, develop dark bands, change color, or lift away from the nail bed over multiple cycles.
Peripheral Neuropathy: Numbness, tingling, or a "pins-and-needles" burning sensation in your fingers and toes.
Severe tiredness (fatigue), mouth sores (mucositis), temporary diarrhea, nausea, or altered taste.
What signs of an infection require immediate emergency hospital attention?
Because Docetaxel temporarily lowers your immune cells, a minor infection can rapidly become life-threatening. Contact your oncology team or rush to the nearest emergency room immediately if you develop a fever of 38°C (100.4°F) or higher, uncontrollable chills, sudden sweating, a new cough, burning when urinating, or sudden shortness of breath.
What should I do if I notice sudden swelling in my feet or ankles at home?
Mild-to-moderate swelling is a known side effect of fluid retention caused by the medication. However, if you experience rapid swelling in your lower legs, a sudden increase in weight, or develop a dry cough and shortness of breath while resting, inform your oncology team immediately so they can evaluate your fluid balance.
How should an 80mg/2mL vial of Docetaxel be stored before use?
Unopened vials should be stored upright in their original cardboard carton to protect them from direct light. Store the box in a cool room strictly between 2°C and 25°C. Do not freeze the vial, as extreme cold can destabilize the concentrated solution.
Advanced intravenous oncology therapies require absolute temperature regulation, specialized handling protocols, and rigorous supply chain validation to guarantee active ingredient stability and safeguard patient outcomes. Institutional hospital procurement, emergency oncology day-case stock replenishment, and verified batch delivery can be securely coordinated via Sanlive Pharmacy & Stores for rapid, climate-controlled, and tamper-evident delivery directly to registered cancer centers, teaching hospitals, and accredited private oncology wings within Lagos, Abuja, Port Harcourt, and nationwide via our authenticated clinical logistics networks.
Important Notice: This information is for educational and institutional procurement support purposes only. Docetaxel is an ultra-high-potency cytotoxic chemotherapy agent. All preparation, dosing calculations, and infusions must be managed exclusively under the direct, physical supervision of a registered Consultant Oncologist or oncology practitioner. If a patient shows signs of an immediate hypersensitivity reaction during the infusion (such as sudden facial flushing, severe shortness of breath, chest tightness, or a rapid drop in blood pressure), halt the infusion immediately and activate emergency clinical life-support protocols.
No reviews yet — be the first!
Log in to write a review.
.jpg)
